G3 Global records highest revenue in Year 2021 on higher COVID-19 test kit distribution...

Turnaround expected by Q3, 2022 as the Group is positive on the outlook of ICT & Healthcare divisions Artificial Intelligence specialist G3 Global Berhad...

Allied Energy, Inc (OTC: AGGI) wins majority stake in WeLife Technology Corp

Allied Energy, Inc (OTC: AGGI) has won control of a majority stake in WeLife Technology Corp via a tender for the company's shares, whose...

Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31...

Q&M Dental Group (Singapore) Limited ("Q&M" or together with its subsidiaries, the "Group"), a leading private dental healthcare group in Asia, today reported the...

UMP Healthcare Offers Free Telemedicine Service to COVID-19 Patients

UMP Healthcare Holdings Limited (UMP or the Group; HKG: 722) has announced that its affiliate, UMP Charity Foundation Limited (the Charity Foundation), will donate...

Lepu Biopharma Co., Ltd. Successfully Listed on the Main Board of HKEX

First Day Closed at HK$7.14, HK$0.01 Higher Than the Offer Price Representing an Increase of Approximately 0.14% The biopharmaceutical company focusing on oncology therapeutics...

MBMV invests in international bio-tech startup Arcensus GmbH

Based on Whole Genome Sequencing (WGS), Arcensus GmbH makes it possible to detect rare as well as frequent disorders such as cancer or heart...

Alset Capital Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full...

Alset Capital Acquisition Corp. (the "Company") announced today the closing of its initial public offering of 7,500,000 units at $10.00 per unit (the "Offering")....

EC Healthcare Included in the Hang Seng Composite Index & Hang Seng Stock Connect...

EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...

V-01 as a Sequential Booster Can Produce Good Protection against Omicron —- Latest Phase...

Global pandemic control is still facing enormous challenges after more than two years since the outbreak of the COVID-19. Following the Delta and Beta...

Bintai Kinden Corporation Berhad Emerges as Substantial Shareholder in Malaysian Genomics Resource Centre Berhad

Malaysian Genomics Resource Centre Berhad ("MGRC" or "the Group"), a leading genomics and biopharmaceutical specialist, is pleased to announce the entry of a new...

Therapeutic Goods Administration of Australia Authorizes Moderna’s Covid-19 Vaccine in Children (6-11 Years)

Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has...
SinoMab

IND Application for SinoMab’s First-in-Class Asthma Therapeutic Product SM17 Accepted by FDA

SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company dedicated to the research,...

Malaysian Genomics Resource Centre Berhad Records Significant Increase in Revenue of RM7.63 Million

Malaysian Genomics Resource Centre Berhad ("MGRC" or "the Group"), a leading genomics and biopharmaceutical specialist, today announced that it recorded revenue of RM7.63 million...

EC Healthcare Acquires Multi-Disciplinary Medical Services Centers

First Foray into Macau Dental Market Strengthen Chronic Disease Management Business Further Fortify Leadership in GBA Discretionary Medical Market EC Healthcare (the Company, which...

Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries

Announcement reinforces Moderna's commitment to Asia and vision as a global commercial enterprise New subsidiaries to be established in Malaysia, Taiwan, Singapore, and...

EC Healthcare Opens New Healthcare Medical Centre, Further Consolidate the Leading Position and Expand...

EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...

Lepu Biopharma Announces Proposed Listing on the Main Board of the Hong Kong Stock...

Offer Price Between HK$6.87and HK$7.38 per H Share To Raise Proceeds Up to HK$936.3 Million Established an integrated end-to-end platform across drug discovery, clinical development and...

Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report

Novotech, the leading Asia Pacific biotech specialist CRO, has been recognized as a top 10 CRO in the 2021 CenterWatch Global Site Relationship Benchmark...

Oculis appoints Dr. Bastian Dehmel as Chief Development Officer

Oculis S.A. (Oculis), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, announces the further...
SinoMab

SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE

SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, stock code: HKG: 3681), a Hong Kong-based biopharmaceutical company dedicated to...